Egemen Küçük1, İbrahim Kocayiğit2, Candan Günel3, Hasan Düzenli4. 1. Department of Emergency Medicine, Training and Research Hospital, Sakarya University, Sakarya 54000, Turkey. 2. Department of Cardiology, Training and Research Hospital, Sakarya University, Sakarya 54000, Turkey. 3. Department of Anaesthesiology, Training and Research Hospital, Sakarya University, Sakarya 54000, Turkey. 4. Department of Chest Diseases, Training and Research Hospital, Sakarya University, Sakarya 54000, Turkey.
Abstract
BACKGROUND: This study aims to evaluate the results of studies investigating neutrophil-to-lymphocyte ratio (NLR) and to identify the prognostic and diagnostic value of NLR in occlusive vascular diseases. METHODS: With the aim of identifying the studies related to NLR, a search was performed on http://www.ncbi.nlm.nih.gov/pubmed by using the key words "neutrophil lymphocyte ratio" between January 2005 and December 2014. All of the original articles were evaluated according to date of publications, countries, clinics and topics. Studies about occlusive vascular diseases were evaluated according to their qualifications, review methods and results. SPSS for Windows 16.0 was used in data analysis and data were expressed as mean, standard deviation and percentage. RESULTS: A total of 735 original research articles were investigated. The number of publications have shown a regular logarithmic increase over the years. Thirty-two percent of all publications were performed by clinics in Turkey and 56.4% were performed by general-oncological surgery and cardiology clinics. A total of 107 publications were identified to be about occlusive vascular diseases, 80.3% of these publications were found to be prognostic and 19.6% to be diagnostic, 82.2% of them were found to be planned as retrospective and 17.7% as prospective. In 95.3% of prognostic publications, there was a positive correlation between high NLR values at admission and poor prognosis. In 95.3% of diagnostic publications high NLR values at admission were identified to be significant diagnostically. CONCLUSION: Elevated neutrophil-to-lymphocyte ratio at admission, could be used as a diagnostic and/or prognostic parameter in occlusive vascular diseases.
BACKGROUND: This study aims to evaluate the results of studies investigating neutrophil-to-lymphocyte ratio (NLR) and to identify the prognostic and diagnostic value of NLR in occlusive vascular diseases. METHODS: With the aim of identifying the studies related to NLR, a search was performed on http://www.ncbi.nlm.nih.gov/pubmed by using the key words "neutrophil lymphocyte ratio" between January 2005 and December 2014. All of the original articles were evaluated according to date of publications, countries, clinics and topics. Studies about occlusive vascular diseases were evaluated according to their qualifications, review methods and results. SPSS for Windows 16.0 was used in data analysis and data were expressed as mean, standard deviation and percentage. RESULTS: A total of 735 original research articles were investigated. The number of publications have shown a regular logarithmic increase over the years. Thirty-two percent of all publications were performed by clinics in Turkey and 56.4% were performed by general-oncological surgery and cardiology clinics. A total of 107 publications were identified to be about occlusive vascular diseases, 80.3% of these publications were found to be prognostic and 19.6% to be diagnostic, 82.2% of them were found to be planned as retrospective and 17.7% as prospective. In 95.3% of prognostic publications, there was a positive correlation between high NLR values at admission and poor prognosis. In 95.3% of diagnostic publications high NLR values at admission were identified to be significant diagnostically. CONCLUSION: Elevated neutrophil-to-lymphocyte ratio at admission, could be used as a diagnostic and/or prognostic parameter in occlusive vascular diseases.
Authors: William R Hiatt; Jerry Goldstone; Sidney C Smith; Mary McDermott; Gregory Moneta; Roberta Oka; Anne B Newman; William H Pearce Journal: Circulation Date: 2008-12-16 Impact factor: 29.690
Authors: Eftal Murat Bakirci; Selim Topcu; Kamuran Kalkan; Ibrahim Halil Tanboga; Abdurrezzak Borekci; Serdar Sevimli; Mahmut Acikel Journal: Clin Appl Thromb Hemost Date: 2013-06-27 Impact factor: 2.389
Authors: Eşref Akıl; Mehmet Ata Akıl; Sefer Varol; Hasan Hüseyin Özdemir; Yavuz Yücel; Demet Arslan; Abdurahman Akyüz; Sait Alan Journal: J Stroke Cerebrovasc Dis Date: 2014-09-06 Impact factor: 2.136
Authors: Orhan Doğdu; Mahmut Akpek; Mikail Yarlıoğlueş; Nihat Kalay; Idris Ardıç; Deniz Elçik; Omer Senarslan; Mehmet Güngör Kaya Journal: Turk Kardiyol Dern Ars Date: 2012-12
Authors: Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; Jeroen G Lijmer; David Moher; Drummond Rennie; Henrica C W de Vet Journal: Clin Chem Date: 2003-01 Impact factor: 8.327
Authors: Lennart Nilsson; Wouter G Wieringa; Gabija Pundziute; Marcus Gjerde; Jan Engvall; Eva Swahn; Lena Jonasson Journal: PLoS One Date: 2014-09-30 Impact factor: 3.240
Authors: Heather E Soder; Amber M Berumen; Kira E Gomez; Charles E Green; Robert Suchting; Margaret C Wardle; Jessica Vincent; Antonio L Teixeira; Joy M Schmitz; Scott D Lane Journal: Clin Psychopharmacol Neurosci Date: 2020-02-29 Impact factor: 2.582